The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Current severe psoriasis and the Rule of Tens
Abstract
This review addresses the problems of defining severity of psoriasis. Concepts of severity depend on the timescale perspective from which judgement is made. Measurement needs to include assessment of signs, impact on the patient's life and the history of the disease. The concept of severity in relationship to quality of life measurement scores has been defined, so it is now possible to postulate a standard, easily remembered concept to help define 'severe psoriasis' in the clinic. The proposed Rule of Tens for current severe psoriasis from the clinician's viewpoint is: 'Current Severe Psoriasis = Body Surface Area involved > 10% or Psoriasis Area and Severity Index score > 10 or Dermatology Life Quality Index score > 10'.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use
FINLAY, A. Y., & KHAN, G. K. (1994) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.1994.tb01167.x · Cited by 5,586
Self-citationSevere Psoriasis – Oral Therapy with a New Retinoid
Fredriksson, T., & Pettersson, U. (2009) · Dermatologica · doi:10.1159/000250839 · Cited by 2,718
Psoriasis causes as much disability as other major medical diseases
Rapp, S. R., Feldman, S. R., Exum, M. L., Fleischer, A. B., & Reboussin, D. M. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70112-x · Cited by 1,491
Etanercept as Monotherapy in Patients with Psoriasis
Leonardi, C. L., Powers, J. L., Matheson, R. T., Goffe, B. S., Zitnik, R., Wang, A., & Gottlieb, A. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030409 · Cited by 1,175
Stern, R. S., Nijsten, T., Feldman, S. R., Margolis, D. J., & Rolstad, T. (2004) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1046/j.1087-0024.2003.09102.x · Cited by 732
Chren, M.-M., Lasek, R. J., Quinn, L. M., Mostow, E. N., & Zyzanski, S. J. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12365600 · Cited by 699
Langley, R. G., & Ellis, C. N. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.04.012 · Cited by 614
The effect of severe psoriasis on the quality of life of 369 patients
Finlay, A. Y., & Coles, E. C. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1995.tb05019.x · Cited by 550
Self-citation10 Years Experience of the Dermatology Life Quality Index (DLQI)
Lewis, V., & Finlay, A. Y. (2004) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1111/j.1087-0024.2004.09113.x · Cited by 479
Self-citationQuality of Life in Patients with Psoriasis: A Systematic Literature Review
de Korte, J., Mombers, F. M. C., Bos, J. D., & Sprangers, M. A. G. (2004) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1046/j.1087-0024.2003.09110.x · Cited by 441
Psoriasis-an index of disability
FINLAY, A. Y., & KELLY, S. E. (1987) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.1987.tb01844.x · Cited by 334
Self-citationAshcroft, Po, L. W., Williams, & Griffiths (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.02963.x · Cited by 287
Carlin, C. S., Feldman, S. R., Krueger, J. G., Menter, A., & Krueger, G. G. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2003.09.014 · Cited by 278
The Self-Administered Psoriasis Area and Severity Index Is Valid and Reliable
Feldman, S. R., Fleischer, A. B., Reboussin, D. M., Rapp, S. R., Lyn Exum, M., Clark, A. R., & Nurre, L. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12329912 · Cited by 267
Prevalence of symptoms experienced by patients with different clinical types of psoriasis
Sampogna, F., Gisondi, P., Melchi, C. F., Amerio, P., Girolomoni, G., Abeni, D., & The Idi Multipurpose Psoriasis Research on Vital Experiences (Improve) Investigators (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.06093.x · Cited by 202
The Psoriasis Life Stress Inventory: a preliminary index of psoriasis-related stress.
Gupta, M. A., & Gupta, A. K. (1995) · Acta Dermato-Venereologica · doi:10.2340/0001555575240243 · Cited by 196
Assessment of Disease Progress in Psoriasis
Marks, R. (1989) · Archives of Dermatology · doi:10.1001/archderm.125.2.235 · Cited by 195
Biological therapies in the systemic management of psoriasis: International Consensus Conference
Sterry, W., Barker, J., Boehncke, W.-H., Bos, J. D., Chimenti, S., Christophers, E., De La Brassinne, M., Ferrandiz, C., Griffiths, C., Katsambas, A., et al. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.06070.x · Cited by 194
Sampogna, F., Sera, F., & Abeni, D. (2004) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2003.09101.x · Cited by 191
Measurement of involved surface area in patients with psoriasis
RAMSAY, B., & LAWRENCE, C. M. (1991) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1991.tb04952.x · Cited by 188
The Salford Psoriasis Index: an holistic measure of psoriasis severity
Kirby, B., Fortune, D. G., Bhushan, M., Chalmers, R. J. G., & Griffiths, C. E. M. (2000) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2000.03418.x · Cited by 178
Quality of life in 6497 Nordic patients with psoriasis
Zachariae, R., Zachariae, H., Blomqvist, K., Davidsson, S., Molin, L., MOrk, C., & Sigurgeirsson, B. (2002) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2002.04742.x · Cited by 173
Physical and psychologic measures are necessary to assess overall psoriasis severity
Kirby, B., Richards, H. L., Woo, P., Hindle, E., Main, C. J., & Griffiths, C. E. M. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.114592 · Cited by 162
The Burden of Psoriasis Is Not Determined by Disease Severity Only
Heydendael, V. M. R., de Borgie, C. A. J. M., Spuls, P. I., Bossuyt, P. M., Bos, J. D., & de Rie, M. A. (2004) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1111/j.1087-0024.2004.09115.x · Cited by 154
McKenna, S. P., Cook, S. A., Whalley, D., Doward, L. C., Richards, H. L., Griffiths, C. E. M., & Van Assche, D. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05492.x · Cited by 147
A quantitative definition of severe psoriasis for use in clinical trials
Feldman, S. R. (2004) · Journal of Dermatological Treatment · doi:10.1080/09546630310019382 · Cited by 112
AAD consensus statement on psoriasis therapies
Callen, J. P., Krueger, G. G., Lebwohl, M., McBurney, E. I., Mease, P. J., Menter, A., Paller, A. S., Pariser, D. M., Weinblatt, M. E., & Zimmerman, G. M. (2003) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(03)01870-x · Cited by 112
Feldman, S. R., Menter, A., & Koo, J. Y. M. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.05697.x · Cited by 103
Nichol, M. B., Margolies, J. E., Lippa, E. A., et al. (1996) · PharmacoEconomics · doi:10.2165/00019053-199610060-00010 · Cited by 97
Psoriasis disease severity measures: comparing efficacy of treatments for severe psoriasis
Weisman, S. M., Pollack, C., & Gottschalk, R. (2003) · Journal of Dermatological Treatment · doi:10.1080/09546630310013360 · Cited by 87
Schiffner, R., Schiffner-Rohe, J., Gerstenhauer, M., Hofstädter, F., Landthaler, M., & Stolz, W. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05156.x · Cited by 70
On the limitations of the psoriasis area and severity index (PASI)
van de Kerkhof, P. C. M. (1992) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1992.tb07827.x · Cited by 67
Harari, M., Shani, J., Hristakieva, E., Stanimirović, A., Seidl, W., & Burdo, A. (2000) · International Journal of Dermatology · doi:10.1046/j.1365-4362.2000.00017.x · Cited by 57
Burns area estimation—an error perpetuated
Jose, R. M., Roy, D. K., Vidyadharan, R., & Erdmann, M. (2004) · Burns · doi:10.1016/j.burns.2004.01.019 · Cited by 50
Rosacea fulminans in pregnancy
Lewis, V. J., Holme, S. A., Wright, A., & Anstey, A. V. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.06190.x · Cited by 28
Measuring severity of psoriasis: methodological issues
Exum, M. L., Rapp, S. R., Feldman, S. R., Fleischer, A., Jr., Reboussin, D. M., & Clark, A. (1996) · Journal of Dermatological Treatment · doi:10.3109/09546639609089544 · Cited by 26
The dermatology life quality index (DLQI) provides qualitatively different information from the pasi
Kimball, A. B., Krueger, G. G., & Woolley, J. M. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2003.10.547 · Cited by 13
Cited by
Greb, J. E., Goldminz, A. M., Elder, J. T., Lebwohl, M. G., Gladman, D. D., Wu, J. J., Mehta, N. N., Finlay, A. Y., & Gottlieb, A. B. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.82 · Cited by 922
Self-citationDefinition of treatment goals for moderate to severe psoriasis: a European consensus
Mrowietz, U., Kragballe, K., Reich, K., Spuls, P., Griffiths, C. E. M., Nast, A., Franke, J., Antoniou, C., Arenberger, P., Balieva, F., et al. (2011) · Archives of Dermatological Research · doi:10.1007/s00403-010-1080-1 · Cited by 898
Basra, M. K. A., Fenech, R., Gatt, R. M., Salek, M. S., & Finlay, A. Y. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08832.x · Cited by 789
Self-citationPathirana, D., Ormerod, A., Saiag, P., Smith, C., Spuls, P., Nast, A., Barker, J., Bos, J., Burmester, G., Chimenti, S., et al. (2009) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2009.03389.x · Cited by 703
Menter, A., Feldman, S. R., Weinstein, G. D., Papp, K., Evans, R., Guzzo, C., Li, S., Dooley, L. T., Arnold, C., & Gottlieb, A. B. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.07.017 · Cited by 516
Metadata
- Authors
- Finlay, A. Y.
- Venue
- British Journal of Dermatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-05
- Volume
- 152
- Issue
- 5
- Pages
- 861-867
- ISSN
- 0007-0963 (ISSN-L)
- 1365-2133
- OpenAlex
- W2012608901
- Cited by
- 394
- References
- 37
- FWCI
- 4.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.